Fumoy,
It has been a long time between drinks for many small cap stem cell companies - but like the tide these things change. Cynata has brilliant timing in this regard.
There will be a lot of people and brokers running there ruler over cyp thinking what added value could this company have to an existing stem cell company and for that matter specific treatment.
$2-4 target for cynata, page-5
-
- There are more pages in this discussion • 386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 19.5¢ | $18.97K | 94.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4999 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |